People · Operator
Named in public records as an officer, director or promoter · active 2023–2023 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Kanvas Biosciences, Inc. | — | Biotech / Pharma | Series A | $15.7M | $23.7M | 2023 |
Iwijn De Vlaminck at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Iwijn De Vlaminck on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jason Pontin | 1 | 5 |
| Justin Smithline | 1 | 4 |
| Matthew Cheng | 1 | 3 |
| Paul Theunissen | 1 | 1 |
| Hao Shi | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.